Stem Cell Therapy for Spinal Cord Injury: Investigating the Path to Neural Regeneration and Functional Restoration

Spinal cord injury (SCI) is a debilitating condition with limited treatment options and persistent neurological deficits. Recent advancements in stem cell-based therapies offer promising regenerative approaches to spinal cord repair. This review synthesizes the current state of stem cell research in SCI, highlighting four primary cell types: embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), and neural stem cells (NSCs). Each cell type offers unique therapeutic benefits, including remyelination, neuroprotection, modulation of inflammation, and circuit reconstruction. Clinical trials have reported varying degrees of success, demonstrating both the potential and limitations of current techniques. Significant barriers remain, including tumorigenesis risk, immune rejection, inconsistent integration, and ethical considerations. The review also explores emerging strategies such as gene editing, biomaterial scaffolds, brain-machine interfaces, immunotherapy, and synthetic biology, underscoring the need for combinatorial and personalized approaches. Although a universal cure remains elusive, these multi-modal innovations mark substantial progress toward functional recovery and long-term spinal cord regeneration.